Donna Wedgeworth
Family · Forest, MSNPI 1952865214
Payments from drug & device makers
Across 152 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$576
- GSK$420
- Merck$252
- AbbVie$219
- Abbott$198
- plus $710 from 15 others
What the payments were for
- Food & beverage$3,44798%
- Education$552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $1,127 |
| Novo Nordisk | 21 | $576 |
| GSK | 18 | $420 |
| Merck | 11 | $252 |
| AbbVie | 13 | $219 |
| Abbott | 12 | $198 |
| Lilly USA, LLC | 9 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $103 |
| Astellas Pharma US Inc | 3 | $85 |
| Biogen | 3 | $50 |
| Bayer | 3 | $47 |
| Boehringer Ingelheim | 2 | $43 |
| Amgen | 2 | $29 |
| Lundbeck LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,502 in reported general payments places this provider in the 85th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $20,581 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $20,165 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $18,498 |
| XareltoRivaroxaban | 27 | $14,814 |
| LinzessLinaclotide | 21 | $12,034 |
| JardianceEmpagliflozin | 15 | $12,001 |
| EliquisApixaban | 12 | $11,896 |
| JanuviaSitagliptin Phosphate | 13 | $11,256 |
| FarxigaDapagliflozin Propanediol | 12 | $10,470 |
| TrulicityDulaglutide | 11 | $10,448 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $9,169 |
| Gabapentin | 80 | $2,255 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,709 |
| DilantinPhenytoin Sodium Extended | 11 | $1,559 |
| Atorvastatin Calcium | 159 | $1,161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $576 | $20,58117 claims |
| GSKTrelegy Ellipta | $420 | $20,16532 claims |
| Johnson & JohnsonXarelto | $13 | $14,81427 claims |
| AbbVieLinzess | $219 | $12,03421 claims |
| Boehringer IngelheimJardiance | $43 | $12,00115 claims |
| MerckJanuvia | $252 | $11,25613 claims |
| AstraZenecaFarxiga | $1,127 | $10,47012 claims |
| Lilly USA, LLCTrulicity | $142 | $10,44811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,007 family providers in Mississippi.
Other family in Forest
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.